US2003017165A1PendingUtilityA1
Chemically programmable immunity
Priority: Dec 22, 1999Filed: Jun 21, 2002Published: Jan 23, 2003
Est. expiryDec 22, 2019(expired)· nominal 20-yr term from priority
Inventors:Kary B. Mullis
A61P 37/04A61K 2039/6025A61K 39/385Y02A50/30
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention is related to methods and compositions that are capable of immediately immunizing a human or animal against any molecule or compound. The present invention comprises an immunity linker molecule with at least two sites; (1) a first binding site that binds to an immune system molecule in a human or animal that has been preimmunized against the first binding site, and (2) one or more second binding sites that bind specifically to a desired compound or molecule. The first binding site and the second binding site(s) are linked by a linker portion of the molecule.
Claims
exact text as granted — not AI-modified1 . An immunity linker molecule, the immunity linker molecule containing at least one first site that binds to an immune system molecule and at lease one second site that binds to a desired compound or molecule.
2 . The immunity linker molecule of claim 1 wherein the first site binds to an antibody.
3 . The antibody of claim 2 wherein the antibody is from a human or animal that has been preimmunized against the first site.
4 . The immunity linker molecule of claim 1 , wherein the desired compound or molecule is a microorganism.
5 . The immunity linker molecule of claim 4 wherein the microorganism is a bacteria, virus, or fungus.
6 . The immunity linker molecule of claim 1 , wherein the compound or molecule is a drug.
7 . The immunity linker molecule of claim 1 , wherein the immunity linker molecule is an aptomer.
8 . A method of immunizing a human or animal against a molecule or compound comprising administering to the human or animal an immunity linker molecule, the immunity linker molecule containing at least one first site second site that binds to a desired compound or molecule.
9 . The method of claim 8 , wherein the human or animal has been preimmunized against the first site on the immunity linker molecule.
10 . The method of claim 8 , wherein the immunity the desired compound or molecule is a microorganism.
11 . The method of claim 10 wherein the microorganism is a bacteria, virus, or fungus.
12 . The method of claim 8 , wherein the compound or molecule is a drug.
13 . The method of claim 1 , wherein the immunity linker molecule is an aptomer.
14 . A method of preimmunizing a human or animal comprising immunizing a human or animal against a molecule that contains a first site that is immunogenic, the first site being present on an immune linker molecule, the immune linker molecule also containing at lease one second site that binds to a desired compound or molecule.Join the waitlist — get patent alerts
Track US2003017165A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.